Sildenafil Tablet, Film Coated
Product Images NDC 50090-7963

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50090-7963). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907963)

Label Image (Lbl500907963)
This is a product description for "sempepee" with the product number 6802-0. It contains 25mg of Sildenafil, USP and comes in a pack of 16 tablets.*
FDA Label Image

Figure 1 (Sildenafil Fig1)

Figure 1 (Sildenafil Fig1)
This is a study providing information on changes in sitting systolic blood pressure of healthy volunteers after receiving either 100mg of Sildenafil or a placebo over a period of time post-dose. The data presents pre-dose and post-dose blood pressure readings.*
FDA Label Image

Figure 2 (Sildenafil Fig2)

Figure 2 (Sildenafil Fig2)
This text provides information about changes in systolic blood pressure (SBP) in millimeters of mercury (mmHg) for different time points postdose for a study involving Doxazosin + Placebo and Doxazosin + Sildenafil 25 mg. The figure includes data for Day 2, 3, 4, 5, 6, 7, and 8. The text indicates the mean standing systolic blood pressure change from baseline.*
FDA Label Image

Figure 3 (Sildenafil Fig3)

FDA Label Image

Figure 4 (Sildenafil Fig4)

Figure 4 (Sildenafil Fig4)
This is a comparison chart showing the mean change in standing systolic blood pressure from baseline after dosing with Doxazosin + Sildenafil 100 mg and Doxazosin + Placebo at different time points.*
FDA Label Image

Figure 5 (Sildenafil Fig5)

Figure 5 (Sildenafil Fig5)
This text includes information about the mean Sildenafil plasma concentrations in healthy male volunteers over time after receiving a commercial tablet dose. The data on plasma concentrations is presented in a graph that shows measurements at different time points post-dose in hours.*
FDA Label Image

Figure 6. Effect Of Sildenafil And Placebo On Maintenance Of Erection By Baseline Score (Sildenafil Fig6)

Figure 6. Effect Of Sildenafil And Placebo On Maintenance Of Erection By Baseline Score (Sildenafil Fig6)
This is not a readable text.*
FDA Label Image

Sildenafile Fig 7 (Sildenafil Fig7)

FDA Label Image

Structure (Sildenafil Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.